Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Frontiers in Neuroscience|July 5, 2016
Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening MethodologiesKatarina Nikolic, Lazaros Mavridis, Teodora Djikic, et al.Analytical and Bioanalytical Chemistry|June 16, 2019
The evaluation of short- and long-term stability studies for brimonidine in aqueous humor by DPV/BDDE method-possible application for direct assay in native samplesValentina Radulović, Mara Aleksić, Vera Kapetanović, et al.ACS Medicinal Chemistry Letters|June 22, 2019
Extending Cross Metathesis To Identify Selective HDAC Inhibitors: Synthesis, Biological Activities, and ModelingSamuel Bouchet, Camille Linot, Dusan Ruzic, et al.European Journal of Medicinal Chemistry|February 18, 2014
Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's diseaseOscar M Bautista-Aguilera, Gerard Esteban, Irene Bolea, et al.Drug Design, Development and Therapy|November 8, 2014
Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybridsOscar M Bautista-Aguilera, Gerard Esteban, Mourad Chioua, et al.Progress in Neurobiology|January 23, 2016
Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's diseaseLhassane Ismaili, Bernard Refouvelet, Mohamed Benchekroun, et al.Bioorganic & Medicinal Chemistry|June 7, 2016
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicinJelica Vucicevic, Tatjana Srdic-Rajic, Marco Pieroni, et al.Journal of Computer-Aided Molecular Design|November 27, 2014
Predicting targets of compounds against neurological diseases using cheminformatic methodologyKatarina Nikolic, Lazaros Mavridis, Oscar M Bautista-Aguilera, et al.Journal of Medicinal Chemistry|November 25, 2014
N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitorOscar M Bautista-Aguilera, Abdelouahid Samadi, Mourad Chioua, et al.Molecules (Basel, Switzerland)|November 17, 2017
The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †Pavel Mucaji, Atanas G Atanasov, Andrzej Bak, et al.Pageof 5